Neonatal Jaundice

Globally, health care providers worldwide recognize that severe neonatal jaundice is a “silent” cause of significant neonatal morbidity and mortality.

15

OVER 60% OF ALL NEWBORNS DEVELOP NEONATAL JAUNDICE

150

AROUND 15% TO 45% OF NEWBORNS DEVELOP SEVERE NEONATAL JAUNDICE IN DEVELOPING COUNTRIES

20

AROUND 10% OF NEWBORNS DIE DUE TO NEONATAL JAUNDICE ALL OVER THE WORLD

12

ALMOST 20% OF THE JAUNDICE BABIES IN INDIA ALONE ,DIE DUE TO SEVERE NEONATAL JAUNDICE

Challenge

Nearly 13 million infants per year globally are unable to process bilirubin quickly enough and require jaundice treatment to prevent death or lifelong disability.

Even though the cure is simple and this condition preventable, existing solutions are unable to address jaundice of different severities resulting in extended therapy time and morbidity.

SLOW TREATMENT

Methods used currently Delay the treatment to 2-3 weeks. Our goal is to reduce the treatment time significantly

SEVERE JAUNDICE CONDITION

Blood transfusion is a miserable solution for severe jaundice cases. Hence, current indigenous methods of maneuvering with multiple devices are not addressing the need.

POST-NATAL SEPARATION

Just after birth separation of her baby lead to Anxiety and accelerates the postnatal trauma. whereas on the other hand, the newborn loses the advantage of initial bond with its mother.

LOW EFFICIENCY

The efficiency of the treatment is directly proportional to optimum irradiance, Exposure of Baby Body Surface Area, and sufficient Hydration via Breastfeeding.